PI-LAB-2026-200

Amycretin, Independent Lab Report

Amycretin 5mg · Northwind Telehealth

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.5% met the stated ≥98% claim. Content measured 98.2% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.5%

Label claimed ≥98%

Content accuracy
98.2%

4.91mg measured against 5mg claimed

Test recency
Current cycle

Published 3 months ago

Specimen PI-LAB-2026-200 Tested by Meridian Bioanalytical 8 samples tested from this company Purity & Testing score 81/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97.5% Within analytical tolerance
Identity (MS) Amycretin Confirmed Matches label
Content 5 mg 4.91 mg Within 5% of label

Methodology & chain of custody

LC-MS/MS identity confirmation with quantitative amino acid analysis.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Meridian Bioanalytical. See our full testing methodology.

Lot / batch
C7468-26
Purchased
Analysed
Published
Laboratory
Meridian Bioanalytical
Test type
Content verification

Original laboratory report: PI-LAB-2026-200-report.pdf (document delivery arrives with the production storage backend)

More Tests, Northwind Telehealth

Tirzepatide (Compounded)
Purity 97.4% Verified
Pemvidutide
Purity 96.5% Verified
Tirzepatide
Purity 97.4% Verified

More Tests, Amycretin

Amycretin BioRegen Research
Purity 98.4% Verified
Amycretin Atlas Peptide Labs
Purity 98.2% Verified
Amycretin Meridian Health Direct
Purity 94.9% Verified